Page last updated: 2024-10-26

emodin and Granulocytic Leukemia, Chronic

emodin has been researched along with Granulocytic Leukemia, Chronic in 7 studies

Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.

Research Excerpts

ExcerptRelevanceReference
"The clinical outcome of chronic myeloid leukemia (CML) patients has been changed dramatically due to the development of imatinib (IM)."1.42Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways. ( Chen, B; Chen, C; Chen, Y; Hu, J; Li, J; Liu, T; Qiu, B; Wang, W; Zheng, J; Zheng, Z, 2015)
"Emodin could cause the regression of tumor."1.36Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. ( Bei-Zhong, L; Chong, W; Chun-Guang, W; Dan, Z; Dan-Ting, J; Jun-Qing, Y; Liang, Z; Yan, W, 2010)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ma, W1
Liu, F1
Yuan, L1
Zhao, C1
Chen, C2
Wang, XY1
Sun, GB1
Wang, YJ1
Yan, F2
Min, H1
Niu, M1
Zhang, W1
Yan, J1
Li, J2
Tan, X1
Li, B1
Su, M1
Di, B1
Chen, Y1
Chen, B1
Qiu, B1
Zheng, Z1
Zheng, J1
Liu, T1
Wang, W1
Hu, J1
Li, BJ1
Liu, TB1
Wang, WF1
Lin, MH1
Hu, JD1
Wang, CG1
Zhong, L1
Liu, YL1
Shi, XJ1
Shi, LQ1
Zeng, L1
Liu, BZ1
Chun-Guang, W1
Jun-Qing, Y1
Bei-Zhong, L1
Dan-Ting, J1
Chong, W1
Liang, Z1
Dan, Z1
Yan, W1

Other Studies

7 other studies available for emodin and Granulocytic Leukemia, Chronic

ArticleYear
Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
    Oncology reports, 2020, Volume: 43, Issue:1

    Topics: beta Catenin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation;

2020
Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells.
    Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:10

    Topics: Allosteric Regulation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Multiple;

2020
Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
    PloS one, 2017, Volume: 12, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Cac

2017
Inhibition of 32Dp210 cells harboring T315I mutation by a novel derivative of emodin correlates with down-regulation of BCR-ABL and its downstream signaling pathways.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:2

    Topics: Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Colony-Forming Units Assay; Down-Regul

2015
[Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1

    Topics: Apoptosis; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Emodin; Fusion Proteins,

2016
Emodin Exerts an Antiapoptotic Effect on Human Chronic Myelocytic Leukemia K562 Cell Lines by Targeting the PTEN/PI3K-AKT Signaling Pathway and Deleting BCR-ABL.
    Integrative cancer therapies, 2017, Volume: 16, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Proliferation; Drug Resistance, Neoplasm

2017
Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
    European journal of pharmacology, 2010, Feb-10, Volume: 627, Issue:1-3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Division; Cell Survival; Emodin; Enzyme Ac

2010